0001641172-25-005108.txt : 20250416 0001641172-25-005108.hdr.sgml : 20250416 20250416171820 ACCESSION NUMBER: 0001641172-25-005108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250414 FILED AS OF DATE: 20250416 DATE AS OF CHANGE: 20250416 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gentry Leesa CENTRAL INDEX KEY: 0002013097 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40738 FILM NUMBER: 25843593 MAIL ADDRESS: STREET 1: 3124 BROTHER BLVD STREET 2: SUITE 104 CITY: BARTLETT STATE: TN ZIP: 38133 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RenovoRx, Inc. CENTRAL INDEX KEY: 0001574094 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 271448452 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2570 W. EL CAMINO REAL, STE. 320, CITY: MOUNTAIN VIEW STATE: CA ZIP: 94040 BUSINESS PHONE: 408-800-2649 MAIL ADDRESS: STREET 1: 2570 W. EL CAMINO REAL, STE. 320, CITY: MOUNTAIN VIEW STATE: CA ZIP: 94040 4 1 ownership.xml X0508 4 2025-04-14 0 0001574094 RenovoRx, Inc. RNXT 0002013097 Gentry Leesa C/O RENOVORX, INC. 2570 W EL CAMINO REAL, SUITE 320 MOUNTAIN VIEW CA 94040 0 1 0 0 Chief Clinical Officer 0 Stock Option 0.8448 2025-04-14 4 A 0 26477 0 A Common Stock 26477 26477 D On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 26,477 shares of the Issuer's common stock (7,173 shares of which are underlying incentive stock options and 19,304 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035. /s/ Leesa Gentry 2025-04-16